ARCOXIA

Arcoxia Adverse Events Reported to the FDA Over Time

How are Arcoxia adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Arcoxia, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Arcoxia is flagged as the suspect drug causing the adverse event.

Most Common Arcoxia Adverse Events Reported to the FDA

What are the most common Arcoxia adverse events reported to the FDA?

Renal Failure Acute	27 (2.75%)
Nausea	25 (2.55%)
Drug Interaction	23 (2.34%)
Melaena	18 (1.83%)
Anaemia	16 (1.63%)
Gastrointestinal Haemorrhage	16 (1.63%)
Drug Ineffective	15 (1.53%)
Duodenal Ulcer	15 (1.53%)
Arthralgia	13 (1.33%)
Diarrhoea	13 (1.33%)
Oedema Peripheral	13 (1.33%)
	Show More
Osteonecrosis	13 (1.33%)
Atrial Fibrillation	12 (1.22%)
Pain In Extremity	12 (1.22%)
Vomiting	12 (1.22%)
Weight Increased	12 (1.22%)
Suicide Attempt	11 (1.12%)
Abdominal Pain Upper	10 (1.02%)
Pain	10 (1.02%)
Gastritis Erosive	9 (.92%)
Malaise	9 (.92%)
Stress	9 (.92%)
Blood Cholesterol Increased	8 (.82%)
Haematemesis	8 (.82%)
Blood Triglycerides Increased	7 (.71%)
Cartilage Injury	7 (.71%)
Drug Intolerance	7 (.71%)
Dyspepsia	7 (.71%)
Face Injury	7 (.71%)
Gait Disturbance	7 (.71%)
General Physical Health Deteriorati...	7 (.71%)
Hand Deformity	7 (.71%)
Hepatic Pain	7 (.71%)
Joint Swelling	7 (.71%)
Mouth Injury	7 (.71%)
Pharyngitis	7 (.71%)
Rheumatoid Arthritis	7 (.71%)
Sinusitis	7 (.71%)
Somnolence	7 (.71%)
Abdominal Pain	6 (.61%)
Bradycardia	6 (.61%)
Chest Pain	6 (.61%)
Constipation	6 (.61%)
Dysgeusia	6 (.61%)
Fatigue	6 (.61%)
Hepatitis Acute	6 (.61%)
Hepatitis Toxic	6 (.61%)
Liver Function Test Abnormal	6 (.61%)
C-reactive Protein Increased	5 (.51%)
Cerebrovascular Accident	5 (.51%)
Death	5 (.51%)
Dehydration	5 (.51%)
Depressed Level Of Consciousness	5 (.51%)
Gastric Ulcer Haemorrhage	5 (.51%)
Hypoaesthesia	5 (.51%)
International Normalised Ratio Incr...	5 (.51%)
Intestinal Ulcer	5 (.51%)
Lethargy	5 (.51%)
Blood Creatinine Increased	4 (.41%)
Deep Vein Thrombosis	4 (.41%)
Depression	4 (.41%)
Dialysis	4 (.41%)
Dizziness	4 (.41%)
Drug Abuse	4 (.41%)
Gastric Ulcer	4 (.41%)
Hypotension	4 (.41%)
Insomnia	4 (.41%)
Intentional Overdose	4 (.41%)
Left Atrial Dilatation	4 (.41%)
Loss Of Consciousness	4 (.41%)
Myocardial Infarction	4 (.41%)
Renal Failure	4 (.41%)
Subileus	4 (.41%)
Urinary Tract Infection	4 (.41%)
Weight Decreased	4 (.41%)
Alanine Aminotransferase Increased	3 (.31%)
Asthenia	3 (.31%)
Benign Prostatic Hyperplasia	3 (.31%)
Blood Alkaline Phosphatase Increase...	3 (.31%)
Blood Glucose Increased	3 (.31%)
Blood Pressure Decreased	3 (.31%)
Bundle Branch Block	3 (.31%)
Cardiac Failure	3 (.31%)
Cardioactive Drug Level Increased	3 (.31%)
Cholelithiasis	3 (.31%)
Confusional State	3 (.31%)
Convulsion	3 (.31%)
Crying	3 (.31%)
Diverticulitis	3 (.31%)
Dyspnoea	3 (.31%)
Gout	3 (.31%)
Haemoglobin Decreased	3 (.31%)
Hepatic Necrosis	3 (.31%)
Hypertension	3 (.31%)
Infection	3 (.31%)
Ischaemic Stroke	3 (.31%)
Nephrotic Syndrome	3 (.31%)
Pancytopenia	3 (.31%)
Platelet Count Decreased	3 (.31%)
Pulmonary Arterial Hypertension	3 (.31%)
Pyrexia	3 (.31%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Arcoxia, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Arcoxia is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Arcoxia

What are the most common Arcoxia adverse events reported to the FDA?

Gastrointestinal Signs	64 (6.52%)
Neurological	51 (5.2%)
Gastrointestinal Hemorrhages	45 (4.59%)
Therapeutic And Nontherapeutic Effe...	45 (4.59%)
Gastrointestinal Ulceration And Per...	43 (4.38%)
Renal Disorders	38 (3.87%)
Joint	33 (3.36%)
Hepatic And Hepatobiliary	32 (3.26%)
Infections - Pathogen Unspecified	30 (3.06%)
Cardiac Arrhythmias	28 (2.85%)
Gastrointestinal Motility And Defec...	22 (2.24%)
	Show More
Anemias Nonhemolytic And Marrow Dep...	21 (2.14%)
Injuries	20 (2.04%)
Lipid Analyses	18 (1.83%)
Hematology Investigations	17 (1.73%)
Physical Examination Topics	16 (1.63%)
Hepatobiliary	15 (1.53%)
Bone Disorders	14 (1.43%)
Epidermal And Dermal Conditions	13 (1.33%)
Musculoskeletal And Connective Tiss...	13 (1.33%)
Anxiety Disorders	12 (1.22%)
Decreased And Nonspecific Blood Pre...	12 (1.22%)
Suicidal And Self-injurious Behavio...	11 (1.12%)
Cardiac And Vascular Investigations	10 (1.02%)
Central Nervous System Vascular	10 (1.02%)
Electrolyte And Fluid Balance Condi...	10 (1.02%)
Musculoskeletal And Connective Tiss...	9 (.92%)
Myocardial	9 (.92%)
Respiratory	9 (.92%)
Bone And Joint Injuries	8 (.82%)
Movement Disorders	8 (.82%)
Arteriosclerosis, Stenosis, Vascula...	6 (.61%)
Coronary Artery	6 (.61%)
Gastrointestinal Inflammatory Condi...	6 (.61%)
Medication Errors	6 (.61%)
Renal And Urinary Tract Investigati...	6 (.61%)
Bacterial Infectious	5 (.51%)
Embolism And Thrombosis	5 (.51%)
Fatal Outcomes	5 (.51%)
Gallbladder	5 (.51%)
Protein And Chemistry Analyses	5 (.51%)
Skin Appendage Conditions	5 (.51%)
Toxicology And Therapeutic Drug Mon...	5 (.51%)
Vascular Hypertensive	5 (.51%)
Cardiac Valve	4 (.41%)
Deliria	4 (.41%)
Depressed Mood Disorders	4 (.41%)
Enzyme	4 (.41%)
Gastrointestinal Stenosis And Obstr...	4 (.41%)
Heart Failures	4 (.41%)
Hematological And Lymphoid Tissue T...	4 (.41%)
Metabolic, Nutritional And Blood Ga...	4 (.41%)
Oral Soft Tissue Conditions	4 (.41%)
Prostatic Disorders	4 (.41%)
Psychiatric	4 (.41%)
Sleep Disorders	4 (.41%)
Body Temperature Conditions	3 (.31%)
Cardiac Disorder Signs	3 (.31%)
Gastrointestinal Vascular Condition...	3 (.31%)
Lipid Metabolism	3 (.31%)
Nephropathies	3 (.31%)
Pulmonary Vascular	3 (.31%)
Purine And Pyrimidine Metabolism	3 (.31%)
Seizures	3 (.31%)
Water, Electrolyte And Mineral	3 (.31%)
Allergic Conditions	2 (.2%)
Appetite And General Nutritional	2 (.2%)
Bile Duct	2 (.2%)
Bone And Joint Therapeutic Procedur...	2 (.2%)
Bone, Calcium, Magnesium And Phosph...	2 (.2%)
Coagulopathies And Bleeding Diathes...	2 (.2%)
Head And Neck Therapeutic Procedure...	2 (.2%)
Headaches	2 (.2%)
Hepatobiliary Therapeutic Procedure...	2 (.2%)
Immunology And Allergy	2 (.2%)
Inner Ear And Viiith Cranial Nerve	2 (.2%)
Lifestyle Issues	2 (.2%)
Manic And Bipolar Mood Disorders	2 (.2%)
Mental Impairment	2 (.2%)
Muscle	2 (.2%)
Mycobacterial Infectious	2 (.2%)
Ocular Infections, Irritations And ...	2 (.2%)
Peripheral Neuropathies	2 (.2%)
Personality Disorders	2 (.2%)
Platelet	2 (.2%)
Procedural And Device Related Injur...	2 (.2%)
Reproductive Neoplasms Male Maligna...	2 (.2%)
Upper Respiratory Tract Disorders	2 (.2%)
Vascular Hemorrhagic	2 (.2%)
Vascular Inflammations	2 (.2%)
White Blood Cell	2 (.2%)
Abdominal Hernias And Other Abdomin...	1 (.1%)
Administration Site Reactions	1 (.1%)
Chemical Injury And Poisoning	1 (.1%)
Disturbances In Thinking	1 (.1%)
Eye	1 (.1%)
Fungal Infectious	1 (.1%)
Gastrointestinal Conditions	1 (.1%)
Glucose Metabolism Disorders	1 (.1%)
Hearing	1 (.1%)
Hemolyses And Related Conditions	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Arcoxia, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Arcoxia is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.